疫苗成分MRC-5含完整人類基因＠喜貓在唱歌－新冠病毒

疫苗無關免疫，重點在注入。注入一股活力與健康嗎？不是。

最近有獨立媒體揭發一些常見疫苗，含有MRC-5。

什麼是MRC-5？

這是藥廠包裝的成分名稱，裏頭是『被墮胎死嬰的細胞』萃取出來的成分，放入疫苗中。也就是，把另一個人完整的基因透過疫苗打進人體裡。裏頭有完整的人類基因序列，含560種致癌基因。

有趣的是，這在美國FDA，CDC(疾病管制中心)，與藥廠(像: 葛蘭素)的網站，都有寫。堂而皇之明擺在那裏，但大眾愚蠢，不知道要問。這就像我聽過最大的謊言就是『你又沒有問….(當然我就不用講，不用提醒你了，而且我沒有掩蓋喔)』

MRC-5等於把死嬰的完整人類基因注入到疫苗中，包括560種致癌基因。

另外要考慮到的是懷這些被墮胎嬰兒的媽媽是怎樣的人？她將怎樣的基因傳給孩子？

除了生理遺傳的基因以外，如果媽媽精神不正常、吸毒、或任何異常的情緒心理，都可能傳給小孩。然後藥廠撿拾這些死胎細胞作為疫苗成分。

所以可否合理推估過去幾十年，人類社會異常的行為失序，犯罪突然飆高，而且形態越來越超乎想像，是否跟這有關？將死胎細胞注入疫苗，等於將隨機殺人、吸毒、精神異常等因子注入到疫苗中，接受注射的人一併接收到。

這是一種毀滅人類的行為呀！

我剛看了一下，麻疹億苗－四痘混合億苗就含有MRC-5。

美國對億苗提出質疑，最不遺餘力的就是小羅伯甘迺迪，他最近甚至打贏億苗官司。

Too crazy.，一群人為了錢，為了不明動機，要大規模毀滅人類，非常不可置信。

或者、如果覺得這樣的資料太科幻低智商，那麼我也要退後一步問，為什麼疫苗要拿人的胚胎、雞的胚胎、我最近在看一戰時，甚至拿馬感染病菌的細胞做億苗成分。

為什麼沒事要把別人的細胞，動物的細胞，放到自己身體裡，以增強體力與免疫力呢？外加部分疫苗還有重金屬。

所以你說接種疫苗是注入毒素，還是在注入免疫力？

影片說明

https://www.youtube.com/watch?v=LxyZHuza4bA&feature=youtu.be&fbclid=IwAR2jRWdcTB4ZcsH5J1po5Rue7RjahTFivYK7LcDwQ5sYUwh4CoU2gS8vFcE

Vaccinegate: MRC-5 contained in Priorix Tetra - Complete genome sequencing

These latest analyses were made possible thanks to the active contribution of the French associations Association Liberté Informations Santé (ALIS), Ligue nationale pour la liberté des vaccinations (LNPLV) and the Australian Association Australian Vaccination-risks Network (AVN), that we thank.

New generation sequencing have become the preferred tool for in-depth analysis in the field of biology and medical science, especially high precision ones. Thanks to these tools, we can approach in a more modern and comprehensive way a number of applications such as de novo sequencing, metagenomic and epigenomic studies, transcriptome sequencing and genome re-sequencing.

This last one (re-sequencing) is largely used in human field, both for research and diagnostic purposes and consists of NGS - Next Generation Sequencing of an entire single genome, to map the Single Nucleotide mutations (SNP), insertions and deletions of more or less long sequences that have occurred in certain locations of the genome, and variations in the number of copies of genomic portions/genes (CNV, Copy Number Variants).

This procedure helps to understand the development mechanism of some pathologies, in order to identify the directions for a future clinical treatment as in the case of cancer for example. Indeed, by this method the genetic heritage of a cancer patient can be fully decoded in both normal and cancerous tissue, thus allowing us to comprehend what exactly has changed within the genome, and, if possible, how to intervene with targeted measures.

The re-sequencing procedure requires that the DNA of an individual is mechanically broken into small dimension fragments (400-500 base pairs) and artificial DNA parts named adapters are tied to these fragments; adapters make it possible to tie the human DNA fragments to a glass surface on which the bases reading (A, C, G, T) is performed. The DNA base pairs reading takes place by means of chemical reactions, namely the incorporation of nucleotides that have been marked by fluorescent molecules. The million sequences (reads) thus obtained are then mapped on the human reference genome by specific software and all the variants are identified comparing the analyzed genome with the reference genome.

This same procedure has been performed on the human genome in Priorix® Tetra lot n. A71CB256A, genome which belongs to cell line MRC-5 (of fetal origin); the work has been carried out by a company in the USA, that routinely deals with human genome re-sequencing analysis. *

*the name of the laboratory that has performed the analysis will be included in the next formal complaint we will file at the Public Prosecutor of Rome and as well at the Italian and European regulatory bodies. The associations who are filing the analysis funded by Corvelva will be promptly kept up to date with these shocking results too. We are no denying that we feel, especially as parents, distressed by these results we are reporting - as if what we have found out so far was not enough to worry about.

Results

The human reference genome was found to be matched by 99.76% reads from vaccine DNA, that means nearly in all its entirety. The human fetal DNA presented in this vaccine is a single entire genome, that means the vaccine contains genomic DNA with all the chromosomes of a male individual (in fact MRC-5 originates from a male fetus).

Given below are the analysis results of different types of variants compared to the reference human genome.

Single nucleotide variant (SNP – single nucleotide polymorphism) and short insertions/deletions (InDels)

DNA single bases variants (SNP) are polymorphisms, which means genetic material mutations of a single nucleotide.

The ‘InDels’ are instead small insertions and deletions of less than 50 bp length and constitute a different class of genomic variants in the human genome.

In the vaccine human genome, 3.6 million SNP have been identified (98.31% of which are already reported in the public database dbSNP and 61.805 new, that means original in this DNA) and about 804.000 InDels (89.42% of which already reported in dbSNP and 85.106 new).

The amount of SNP is in line with what has been reported in literature on/in “typical human genome”, whereas the InDels results in a higher quantity compared to what has been reported by “The 1000 Genomes Project Consortium” namely 800.000 compared to 600.000.

CNV (Copy Number Variants) and SV (Structural Variants)

The copy number variants (CNVs) are genomic variants due to variations in the number of copies of relatively large fragments (longer than 50 bp) between individual genomes. There are two types of CNVs: type "gain" (gain of copies) and type "loss" (loss of copies). 218 CNVs were detected in the human vaccination genome, of which 82 were "gain" (covering a portion of the genome of about 6.9 million base pairs) and 136 CNVs of the "loss" type (covering a portion of the genome of about 70 million bases).

As described by The 1000 Genomes Project Consortium in "A global reference for human genetic variation (Nature, vol. 526, 10 Oct. 2015)" a typical human genome contains from 2,100 to 2,500 large variants including:

1,000 large deletions

160 variants in number of copies (CNVs)

10 inversions

Which together affect the 20 million bases of the sequence, considering the insertions as well.

As seen for the short INDELs, even in the case of large insertions and deletions, the vaccine genome is therefore not in line with a "normal" human genome, being much more "rearranged" than a genome of a common person.

https://www.corvelva.it/it/speciale-corvelva/vaccinegate-en/vaccinegate-mrc-5-contained-in-priorix-tetra-complete-genome-sequencing.html?fbclid=IwAR19SNRlBJFVo2a1g2RQfvq3tobuxlCBQisniwWXWJDEXjHuMyHSgnZvtJA